Novartis AG
NVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $13 | $8 | $12 |
| Short-Term Investments | $2 | $1 | $11 | $16 |
| Receivables | $8 | $9 | $10 | $10 |
| Inventory | $6 | $6 | $7 | $7 |
| Other Curr. Assets | $2 | $1 | $1 | $1 |
| Total Curr. Assets | $30 | $30 | $37 | $46 |
| Property Plant & Equip (Net) | $11 | $11 | $12 | $13 |
| Goodwill | $25 | $23 | $29 | $30 |
| Intangibles | $27 | $27 | $32 | $34 |
| Long-Term Investments | $1 | $2 | $2 | $2 |
| Tax Assets | $4 | $4 | $4 | $4 |
| Other NC Assets | $5 | $2 | $2 | $3 |
| Total NC Assets | $73 | $69 | $81 | $86 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $102 | $100 | $117 | $132 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $5 | $6 |
| Short-Term Debt | $8 | $6 | $6 | $7 |
| Tax Payable | $2 | $2 | $3 | $3 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $13 | $14 | $15 |
| Total Curr. Liab. | $29 | $26 | $29 | $30 |
| LT Debt | $23 | $20 | $22 | $25 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $2 | $3 | $3 |
| Other NC Liab. | $4 | $5 | $5 | $6 |
| Total NC Liab. | $29 | $27 | $29 | $34 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $58 | $53 | $58 | $64 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $47 | $50 | $64 | $71 |
| AOCI | -$3 | -$4 | -$5 | -$4 |
| Other Equity | -$0 | -$0 | -$0 | -$0 |
| Total Equity | $44 | $47 | $59 | $68 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $102 | $100 | $117 | $132 |
| Net Debt | $20 | $13 | $20 | $19 |